B. fragilis has been shown to promote colonic mucosa regeneration in colitis via promotion of IL-22 secretion by ILC3s (53), but Bacteroides sphingolipids have also been shown to exacerbate colitis by inhibiting ILC3-derived IL-22 production (54). Here, IL22 is linked to colitis.